GLPwatch
Trials (2139)
Page 9 of 36.
- Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.
- Exenatide for Smoking Cessation and Prevention of Weight Gain
- A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight
- Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes
- Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only
- Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatide
- Exenatide and Weight Loss for Diabetes Prevention
- Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility
- A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)
- Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)
- A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus
- GLP-1R Agonist Treatment for Opioid Use Disorder
- Binge Eating Liraglutide Intervention
- A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes
- Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)
- A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet
- A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus
- Non-Invasive Hepatic and Metabolic Index Changes After Incretin Therapy in Overweight/Obesity
- Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
- Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity
- A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus
- Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects
- GLP1 Fasting Status and Gastric Retention Using Gastric Ultrasound
- Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male Subjects
- Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes
- Liraglutide Hospital Discharge Trial
- Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets
- A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes
- Liraglutide 3 mg for Knee Osteoarthritis
- Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes
- Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults
- Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity
- The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function
- The Effect of Semaglutide on Cardiovascular Markers and Liver Function
- Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)
- Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)
- Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus
- Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice
- Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide
- Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass
- A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus
- Study That Tests AD109 in Patients Taking GLP-1 Drugs
- Tirzepatide in the Treatment of Cannabis Use Disorder
- A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)
- Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin
- The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and Albuminuria
- Gut Microbiome Changes Following Liraglutide Treatment in Obese Subjects or Overweight Subjects With Co-morbidities
- Risk Factors Affect Weight Loss Outcomes After Treatment.
- Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes
- Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes
- Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss
- A Study of LY3841136 in Japanese Participants With Obesity or Overweight
- Sequential or CombinaTion Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)
- A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity
- A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
- Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss.
- Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes